Skip to main content
. 2003 May 23;100(12):7377–7382. doi: 10.1073/pnas.1230273100

Table 2. Endplate studies.

Controls Patient
[125I]α-bgt binding sites/EP 12.82±0.79 E6 (13) 11.51 E6
Resting membrane potential, mV* -72.5±0.78 (75) -75.5±1.4 (13 fibers)
EPP amplitude, mV ND 42.6±5.05 (12)
Quantal release at 1 Hz 31±1 (190) 36±4.3 (12)
MEPP amplitude, mV§ 1.00±0.025 (165) 1.17±0.08 (9)
Single-channel opening bursts
τ2, ms 0.12±0.012 (32) 0.067±0.0078 (3)
Area 0.16±0.014 0.16±0.025
τ2, ms 3.04±0.175 (34) 2.91±0.32 (3)
Area 0.85±0.015 0.84±0.024

Values indicate mean±SEM. Measurements were made at 30°C for MEPPs and EPPs and at 22°C for single-channel recordings. Numbers in parentheses indicate number of subjects for [125I]α-bgt binding sites/EP and number of fibers or EPs for other measurements

*

Measured with 10-15 MΩ glass microelectrodes

Corrected for a resting membrane potential of -80 mV and nonlinear summation

Corrected for a resting membrane potential of -80 mV, nonlinear summation, and non-Poisson release

§

Corrected for resting membrane potential of -80 mV and for a fiber diameter of 50 μm

ACh, 1 μM; pipette potential, 80 mV; bandwidth, 5.8 kHz